[1] Huaringa AJ, Francis WH. Pulmonary alveolar proteinosis:a case report and world literature review[J]. Respirol Case Rep, 2016, 4(6):e00201.
[2] 郭文亮, 曾运祥, 苏柱泉等. 粒细胞-巨噬细胞集落刺激因子雾化吸入治疗自身免疫性肺泡蛋白沉积症一例并文献复习[J]. 中华结核和呼吸杂志, 2015, 38(10):751-755.
[3] Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis[J]. Science, 1994, 264(5159):713-716.
[4] Stanley E, Lieschke G J, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology[J]. Proc Natl Acad Sci U S A, 1994, 91(12):5592-5596.
[5] Nishinakamura R, Nakayama N, Hirabayashi Y, et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal[J]. Immunity, 1995, 2(3):211-222.
[6] Griese M. Pulmonary alveolar proteinosis:a comprehensive clinical perspective[J]. Pediatrics,2017,140(2):e20170610.
[7] 卢惠伦, 罗益锋. 体外膜肺氧合下行全肺大容量灌洗治疗肺泡蛋白沉积症1例并文献复习[J]. 现代医院, 2010, 10(3):13-14.
[8] Xu Z, Jing J, Wang H, et al. Pulmonary alveolar proteinosis in China:a systematic review of 241 cases[J]. Respirology, 2009, 14(5):761-766.
[9] 赵玉月, 徐作军. 肺泡蛋白沉积症的治疗进展[J]. 中华结核和呼吸杂志, 2014, 37(6):444-447.
[10] Bonella F, Bauer PC, Griese M, et al. Pulmonary alveolar proteinosis:new insights from a single-center cohort of 70 patients[J]. Respir Med, 2011, 105(12):1908-1916.
[11] Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis[J]. Am J Respir Crit Care Med, 2001, 163(2):524-531.
[12] Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis[J]. Chest, 2006, 130(1):227-237.
[13] Schoch OD, Schanz U, Koller M, et al. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF[J]. Thorax, 2002, 57(3):277-280.
[14] Anderson PM, Markovic SN, Sloan JA, et al. Aerosol granulocyte macrophage-colony stimulating factor:a low toxicity, lung-specific biological therapy in patients with lung metastases[J]. Clin Cancer Res, 1999, 5(9):2316-2323.
[15] Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis[J]. Am J Respir Crit Care Med, 2010, 181(12):1345-1354.